Lazard Asset Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $420K | Buy |
15,181
+12,310
| +429% | +$341K | ﹤0.01% | 1541 |
|
|
2025
Q1 | $63K | Sell |
2,871
-227
| -7% | -$4.98K | ﹤0.01% | 1943 |
|
|
2024
Q4 | $61K | Buy |
+3,098
| New | +$61K | ﹤0.01% | 1931 |
|
|
2024
Q2 | – | Sell |
-3,607
| Closed | -$71K | – | 2343 |
|
|
2024
Q1 | $71K | Buy |
+3,607
| New | +$71K | ﹤0.01% | 1640 |
|
|
2023
Q4 | – | Sell |
-3,502
| Closed | -$60K | – | 2375 |
|
|
2023
Q3 | $60K | Buy |
+3,502
| New | +$60K | ﹤0.01% | 1798 |
|
|
2023
Q1 | – | Sell |
-4,648
| Closed | -$69K | – | 2435 |
|
|
2022
Q4 | $69K | Buy |
+4,648
| New | +$69K | ﹤0.01% | 1668 |
|
|
2022
Q3 | – | Sell |
-10,546
| Closed | -$102K | – | 2459 |
|
|
2022
Q2 | $102K | Buy |
10,546
+4,826
| +84% | +$46.7K | ﹤0.01% | 1499 |
|
|
2022
Q1 | $56K | Buy |
5,720
+1,961
| +52% | +$19.2K | ﹤0.01% | 1686 |
|
|
2021
Q4 | $44K | Buy |
+3,759
| New | +$44K | ﹤0.01% | 1796 |
|